You are here

  • Home
  • Archive
  • Volume 15, Issue 7
  • Relapse of immune thrombotic thrombocytopenic purpura (iTTP) possibly triggered by COVID-19 vaccination and/or concurrent COVID-19 infection

Article info

Article menu
Download PDFPDF
Case Reports: Rare disease
Relapse of immune thrombotic thrombocytopenic purpura (iTTP) possibly triggered by COVID-19 vaccination and/or concurrent COVID-19 infection

Authors

  1. Correspondence to Dr Katerina Pavenski; katerina.pavenski{at}unityhealth.to
View Full Text

Citation

Fang F, Tse B, Pavenski K
Relapse of immune thrombotic thrombocytopenic purpura (iTTP) possibly triggered by COVID-19 vaccination and/or concurrent COVID-19 infection
BMJ Case Reports CP 2022;15:e247524.

Publication history

  • Accepted July 5, 2022
  • First published July 28, 2022.
Online issue publication 
January 24, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ.